PLK4 and hepatocellular carcinoma: Thus, our data show that YAP inactivation serves as a downstream event of lncRNA PLK4 down‐regulation, and triggers tumour cell senescence, which might be the key mechanism that talazoparib inhibits hepatoma cell growth.